Following a discussion around summarization in Part 1, Part 2 discusses the method of pure abstraction in light of recent advances in deep learning and AI.
Ashutosh Pachisia
Advertisement
Articles by Ashutosh Pachisia
Experimenting with different methods using AI.
Chatbots can benefit regulatory landscape in light of evolving standards and guidelines.
eTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.
Advertisement
Latest Updated Articles
- AI/ML Approaches to Assisted Medical Writing—Part 2
August 24th 2022
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health
2
From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA
3
Comparing OpenAI and Mistral on Clinical Trial Matching
4
From Signal to Action: Why Faster Trial Data Isn’t Producing Faster Decisions
5